[Septicemia caused by MRSA].
Wada
K
K
kawashima
T
T
Tsukasa
H
H
Arakawa
M
M
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002404:Catheterization / Q000009:adverse effects; D003982:Dibekacin / Q000031:analogs & derivatives / Q000627:therapeutic use; D004866:Equipment Contamination; D006801:Humans; D016106:Methicillin Resistance; D011379:Prognosis; D018805:Sepsis / Q000188:drug therapy / Q000382:microbiology*; D013203:Staphylococcal Infections; D013211:Staphylococcus aureus; D014640:Vancomycin / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D003982:Dibekacin; D014640:Vancomycin; C031986:arbekacin